Comprehensive Addiction and Recovery Act
Drug manufacturers profit enormously from the overprescribing of opioids, so the last thing they need is any additional financial incentives from Congress.
A new House bill moves the focus away from recovery.
"I hope that the talk of hearings and markups isn’t an excuse to delay action," Sen. Rob Portman said in a warning to his House colleagues.
The bipartisan CARA bill aims to change drug policy away from punishment and more toward rehabilitation.
The legislators said the bill was "duplicative" and millions had already been appropriated to deal with the national problem.